Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Yiyang Gong; Yun Ke; Zichuan Yu; Jingying Pan; Xuanrui Zhou; Yike Jiang; Minqin Zhou; Hong Zeng; Xitong Geng; Guowen Hu

doi:doi:10.18632/aging.204962

← Back

Research Paper Volume 15, Issue 16 pp 8155—8184

Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Figure 7. RP2 is associated with tumor immune microenvironment in LGG and GBM. (A, B) Correlation between RP2 and immune score and estimated score. (C, D) Correlation between tumor infiltrating immune cells and RP2 expression. (E, F) Correlation between CNV of RP2 and the degree of immune cell infiltration in LGG and GBM.